Your browser doesn't support javascript.
loading
Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin.
Zakharova, E T; Sokolov, A V; Pavlichenko, N N; Kostevich, V A; Abdurasulova, I N; Chechushkov, A V; Voynova, I V; Elizarova, A Yu; Kolmakov, N N; Bass, M G; Semak, I V; Budevich, A I; Kozhin, P M; Zenkov, N K; Klimenko, V M; Kirik, O V; Korzhevskii, D E; Menshchikova, E B; Vasilyev, V B.
Afiliación
  • Zakharova ET; Institute of Experimental Medicine, Saint-Petersburg, Russia.
  • Sokolov AV; Institute of Experimental Medicine, Saint-Petersburg, Russia. biochemsokolov@gmail.com.
  • Pavlichenko NN; Saint-Petersburg State University, Saint-Petersburg, Russia. biochemsokolov@gmail.com.
  • Kostevich VA; Centre of Preclinical Translational Research, Almazov National Medical Research Centre, Saint-Petersburg, Russia. biochemsokolov@gmail.com.
  • Abdurasulova IN; «Trans-Technologies¼ Ltd, Saint-Petersburg, Russia.
  • Chechushkov AV; Institute of Experimental Medicine, Saint-Petersburg, Russia.
  • Voynova IV; Institute of Experimental Medicine, Saint-Petersburg, Russia.
  • Elizarova AY; Centre for Clinical and Experimental Medicine, Novosibirsk, Russia.
  • Kolmakov NN; Institute of Experimental Medicine, Saint-Petersburg, Russia.
  • Bass MG; Institute of Experimental Medicine, Saint-Petersburg, Russia.
  • Semak IV; Institute of Experimental Medicine, Saint-Petersburg, Russia.
  • Budevich AI; Institute of Experimental Medicine, Saint-Petersburg, Russia.
  • Kozhin PM; Belorussian State University, Minsk, Belarus.
  • Zenkov NK; Scientific Practical Centre of Animal Breeding, Zhodino, Belarus.
  • Klimenko VM; Centre for Clinical and Experimental Medicine, Novosibirsk, Russia.
  • Kirik OV; Centre for Clinical and Experimental Medicine, Novosibirsk, Russia.
  • Korzhevskii DE; Institute of Experimental Medicine, Saint-Petersburg, Russia.
  • Menshchikova EB; Institute of Experimental Medicine, Saint-Petersburg, Russia.
  • Vasilyev VB; Institute of Experimental Medicine, Saint-Petersburg, Russia.
Biometals ; 31(3): 425-443, 2018 06.
Article en En | MEDLINE | ID: mdl-29748743
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Eritropoyetina / Fármacos Neuroprotectores / Factor 2 Relacionado con NF-E2 / Neuroprotección / Lactoferrina Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Biometals Asunto de la revista: BIOQUIMICA Año: 2018 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Eritropoyetina / Fármacos Neuroprotectores / Factor 2 Relacionado con NF-E2 / Neuroprotección / Lactoferrina Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Biometals Asunto de la revista: BIOQUIMICA Año: 2018 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Países Bajos